MetLife Investment Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $69.8M | Sell |
580,004
-15,612
| -3% | -$1.8M | 0.36% | 35 |
|
|
2025
Q4 | $62.7M | Sell |
595,616
-24,494
| -4% | -$2.3M | 0.3% | 39 |
|
|
2025
Q3 | $52M | Sell |
620,110
-19,855
| -3% | -$1.64M | 0.25% | 49 |
|
|
2025
Q2 | $50.7M | Sell |
639,965
-127,604
| -17% | -$10.1M | 0.3% | 45 |
|
|
2025
Q1 | $68.9M | Sell |
767,569
-13,906
| -2% | -$1.3M | 0.37% | 31 |
|
|
2024
Q4 | $77.7M | Buy |
781,475
+6,832
| +0.9% | +$704K | 0.42% | 28 |
|
|
2024
Q3 | $88M | Sell |
774,643
-18,630
| -2% | -$2.21M | 0.5% | 25 |
|
|
2024
Q2 | $98.2M | Buy |
793,273
+180,477
| +29% | +$23.2M | 0.58% | 22 |
|
|
2024
Q1 | $80.9M | Sell |
612,796
-21,751
| -3% | -$2.68M | 0.54% | 24 |
|
|
2023
Q4 | $69.2M | Sell |
634,547
-12,641
| -2% | -$1.31M | 0.5% | 25 |
|
|
2023
Q3 | $66.6M | Sell |
647,188
-16,401
| -2% | -$1.77M | 0.52% | 26 |
|
|
2023
Q2 | $76.6M | Sell |
663,589
-32,956
| -5% | -$3.74M | 0.56% | 22 |
|
|
2023
Q1 | $74.1M | Sell |
696,545
-7,736
| -1% | -$835K | 0.53% | 25 |
|
|
2022
Q4 | $78.1M | Sell |
704,281
-12,110
| -2% | -$1.24M | 0.59% | 23 |
|
|
2022
Q3 | $61.7M | Sell |
716,391
-8,343
| -1% | -$745K | 0.51% | 28 |
|
|
2022
Q2 | $66.1M | Buy |
724,734
+37,265
| +5% | +$3.3M | 0.51% | 27 |
|
|
2022
Q1 | $56.4M | Buy |
687,469
+129,382
| +23% | +$10.2M | 0.37% | 41 |
|
|
2021
Q4 | $42.8M | Sell |
558,087
-13,651
| -2% | -$1.09M | 0.35% | 49 |
|
|
2021
Q3 | $42.9M | Sell |
571,738
-15,309
| -3% | -$1.16M | 0.38% | 47 |
|
|
2021
Q2 | $45.7M | Sell |
587,047
-44,869
| -7% | -$3.34M | 0.4% | 40 |
|
|
2021
Q1 | $46.5M | Sell |
631,916
-12,010
| -2% | -$886K | 0.43% | 34 |
|
|
2020
Q4 | $50.3M | Sell |
643,926
-28,129
| -4% | -$2.15M | 0.48% | 27 |
|
|
2020
Q3 | $53.2M | Sell |
672,055
-19,778
| -3% | -$1.55M | 0.58% | 25 |
|
|
2020
Q2 | $51M | Buy |
691,833
+4,073
| +0.6% | +$307K | 0.58% | 24 |
|
|
2020
Q1 | $50.5M | Sell |
687,760
-21,043
| -3% | -$1.65M | 0.69% | 19 |
|
|
2019
Q4 | $61.5M | Sell |
708,803
-21,414
| -3% | -$1.76M | 0.64% | 23 |
|
|
2019
Q3 | $58.7M | Sell |
730,217
-13,519
| -2% | -$1.08M | 0.65% | 23 |
|
|
2019
Q2 | $59.5M | Sell |
743,736
-25,259
| -3% | -$1.93M | 0.64% | 25 |
|
|
2019
Q1 | $61M | Sell |
768,995
-10,365
| -1% | -$775K | 0.66% | 24 |
|
|
2018
Q4 | $56.8M | Sell |
779,360
-31,451
| -4% | -$2.22M | 0.69% | 22 |
|
|
2018
Q3 | $54.9M | Sell |
810,811
-19,167
| -2% | -$1.22M | 0.56% | 27 |
|
|
2018
Q2 | $48.1M | Sell |
829,978
-20,358
| -2% | -$1.15M | 0.57% | 28 |
|
|
2018
Q1 | $44.2M | Sell |
850,336
-36,568
| -4% | -$1.97M | 0.52% | 33 |
|
|
2017
Q4 | $47.6M | Buy |
+886,904
| New | +$49.2M | 0.54% | 31 |
|
Other funds holding MRK
VCM
VPM
MetLife Investment Management's MRK Position: Q1 2026 in Review
MetLife Investment Management reduced its Merck (MRK) stake by 2.6% in Q1 2026, selling an estimated $1.8M and leaving 580,004 shares worth $69.8M. The position accounts for 0.36% of the portfolio, ranked #35.
MetLife Investment Management first reported a position in MRK in Q4 2017 and has held it in 34 quarters since. The position peaked at $98.2M in Q2 2024. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- MetLife Investment Management held 580,004 shares of Merck worth $69.8M as of Q1 2026.
- MetLife Investment Management sold 15,612 Merck shares in Q1 2026, an estimated $1.8M.
- Merck made up 0.36% of MetLife Investment Management's portfolio in Q1 2026, its #35 holding.
- MetLife Investment Management first reported a position in Merck in Q4 2017 and has held it in 34 quarters since.
- MetLife Investment Management's Merck position peaked at $98.2M in Q2 2024.
- 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.